Novel Formulations And Future Trends Recent And Future Trends In Pharmaceutics

Novel Formulations and Future Trends, Volume Three in the Recent and Future Trends in Pharmaceutics series, explores aspects of pharmaceutics with an original approach focused on technology, novelties and future trends. It discusses the most important developments in drug delivery, including important and exciting areas such as mucosal, implantable, transdermal, gastroretentive, vaccine and targeted drug delivery systems. The field of pharmaceutics is highly dynamic and rapidly expanding day-by-day so it demands a variety of amplified efforts for designing and developing pharmaceutical processes and formulation strategies. This is an essential reference for researchers in academia and industry as well as advanced graduate students. New technologies are also explored including 3D printing and computational pharmaceutics. Explores the most recent technologies in drug delivery in detail Contains contributions from the leading experts from academia, research, industry and regulatory agencies Includes high quality illustrations, flow charts and tables for easy understanding of concepts Discusses practical examples and research case studies

From Current to Future Trends in Pharmaceutical Technology explores the current trends of this field and creates a multi-aspect framework for the reader. The book covers topics on pharmaceutics, pharmaceutical engineering, pre-formulation protocols, techniques, innovative excipients, bio-printing techniques, scale-up based on formulas on-a-chip, and regulatory aspects based on new scientific achievements. Modified dosage forms, new aspects on the compatibility of drug excipients interactions, and drug release by various dosage forms are included. Physical pharmacy (physical and biological stability of dosage forms), innovative excipients, patents on innovative formulations and regulatory issues related to the approval process of medicines are also discussed. The book is a valuable resource for a wide audience of academics, industrial researchers and professionals working in this field as the development of efficient and safe medicines is critical to future needs. Includes innovative excipients/advanced materials in pharmaceutics Covers modified release delivery platforms Explores new elements of drug development

Novel Formulations and Future Trends: Recent and Future Trends in Pharmaceutics, Volume 3 explores aspects of pharmaceutics with an original approach focused on technology, novelties and future trends in the field. The field of pharmaceutics is highly dynamic and rapidly expanding day by day, and it demands a variety of amplified efforts for designing and developing pharmaceutical processes and formulation strategies. This book provides practical information for conducting research in pharmaceutics. Novel Formulations and Future Trends is an essential reference for researchers in academia and industry as well as advanced graduate students in pharmaceutics. This book, the third of Recent and Future Trends in Pharmaceutics series, discusses in detail the most recent developments in drug delivery. Important and exciting areas such as recent developments in mucosal, implantable, transdermal, gastroretentive, vaccine and targeted drug delivery systems are included. New technologies are also explored including 3D printing and computational pharmaceutics.

Dosage Forms, Formulation Developments and Regulations, Volume One in the Recent and Future Trends in Pharmaceutics series, explores aspects of pharmaceutics, with an original approach focused on technology, novelties and future trends in the field. The book discusses the most recent developments in pharmaceutical preformulation and formulation studies, biopharmaceutics and novel pharmaceutical formulations, regulatory affairs, and good manufacturing practices. Exciting areas such as formulation strategies, optimization techniques, the biopharmaceutical classification system, and pharmaceutical aerosols are included. The field of pharmaceutics is highly dynamic and rapidly expanding day-by-day, so it demands a variety of amplified efforts for designing and developing pharmaceutical processes and formulation strategies. This is an essential reference for researchers in academia and industry as well as advanced graduate students in pharmaceutics. Examines trends and recent technologies in dosage, formulation and regulation Contains contributions from leading experts in academia, research, industry and regulatory agencies Includes high-quality illustrations, flow charts and tables for easy understanding of concepts Discusses practical examples and research case studies

This Publication Deals With The Problems On The Development Of New Medicine And Herbal Formulations From Natural Products And Traditional Drugs, Technology Transfer In Bulk Drugs Manufacture Through Horizontal Or Vertical Mechanism Preferably Through Joint Venture Between The Companies In The Developing World, Quality Management, R&D On Tropical Diseases, Bio-Evaluation Of Drug Molecules (In Vitro And In Vivo), Provision And Implications Of Trips For Drugs, Manufacturing Facilities And Standards And Modern Methods Of Screening Of Natural Products For Developing New Bioactives. Status Of The Development Of Drugs And Pharmaceutical In Some Of The Developing Countries, Viz., Bangladesh, Egypt, India, Iraq, Indonesia, Malaysia, Mauritius, Nepal, Syria And Zambia Is Also Included In The Publication. Contents Part I: Global Drugs And Pharmaceutical Sector: Situation Analysis Chapter 1: Strategy For Discovering New Therapeutics In Developing Countries By Professor R Kumar; Chapter 2: Drugs And Pharmaceutical Sector In Nam Countries: Implications Of Wto And Trips By Dr (Mrs) Veena Jha; Chapter 3: Current And Emerging Horizons In Global Drugs And Pharmaceutical Sector By Dr (Mrs) Rama Mukherjee. Part Ii: Discovery, Design And Development Of Investigative New Drugs (Inds) Current Trends Chapter 4: Founder S Day Lecture: New Drug Development: An Indian Success Story By Dr Venkateswerlu. Part Iii: Medicinal Plants And Traditional Drugs New Precursors For Inds Chapter 5: Potential Of Medicinal Plants As A Source For New Drugs Development By Dr Tuley De Silva; Chapter 6: Modern Techniques Of Screening Natural Products For Drug Discovery By Dr Mark Butler; Chapter 7: Lead Optimisation For Inds Hiv Protease Inhibitors: From Peptidomimetics To Cyclic Urease By Dr Javed Iqbal. Part Iv: Tools Of Automation For Rational Drug Discovery Chapter 8: Structure-Activity Studies Through Computer Aided Modelling By Dr A K Saxena; Chapter 9: Parallel Synthesis And Combinatorial Libraries By Dr S Raghavan; Chapter 10: Rapid Screening Of Combinatorial Libraries By Dr C Sesagiri Rao. Part V: Process Technologies For Bulk Drugs: Recent Trends And Innovations (Status Of Bulk Drug Processing) Chapter 11: Chemistry Of Important Unit Processes In The Manufacture Of Bulk Drugs And Intermediates By Dr A V Rama Rao; Chapter 12: Clean Process Options: Technological Challenges By Dr A A Khan. Part Vi: Smes In Bulk Drug Sector: Technological Upgradation For Global Competitiveness Chapter 13: Cluster Servicing Approach For Technology Transfer To Smes: An Indian Case Study By Dr K V Raghavan & Dr M Hari Babu; Chapter 14: Proactive Government Policies For Sustainable Growth Under A Competitive Regime By Dr Zafrullah Chowdhury. Part Vii: Quality Management In Drugs And Pharmaceutical Sector (Advance In Instrumental Methods For Bulk Drug Characterisation) Chapter 15: New Drug Development: Pharmacological Screening And Preclinical Toxicity By Dr P V Diwan; Chapter 16: Clinical Evaluation Non-Invasive Clinical Pharmacodynamic Methods In Evaluation Of Drug Effects By Dr Naidu; Chapter 17: Regulatory Aspects Of Drugs And Pharmaceuticals: Trends And Challenges By Dr M Venkateswarlu. Part Viii: Fingerprinting Of Herbal Drugs Chapter 18: Fingerprinting Of Pharmacopoeia For Herbal Drugs By Dr I Sanjeeva Rao; Chapter 19: Good Manufacturing Practices In Drug Industry By Dr P S Ramanathan; Chapter 20: Drug Master Files By Dr R Nageswara Rao. Part Ix: Country Status Report Chapter 21: Egypt: Current Standing Of Drugs And Pharmaceuticals Industry; Chapter 22: India: Drugs And Pharmaceutical: A Macro View; Chapter 23: Inodnesia: Developing Pharmaceuticals Suitable For Indonesian Pharmaceutical Industries; Chapter 24: Iraq: Status Of The Development Of Drugs And Pharmaceuticals Including R&D; Chapter 25: Malaysia: Research And Development In Herbal Medicine Towards Commercialisation Of Herbal Preparation/Drug And The Herbal Medicine Industry; Chapter 26: Mauritius: Drugs And Pharmaceutical Industry; Chapter 27: Nepal: Current Status Of Drugs And Pharmaceutical Industry; Chapter 28: Syria: A National Report On The Current Status Of Drugs And Pharmaceuticals Industry; Chapter 29: Zambia: Country Status Report.

Drug Delivery Trends examines a drift in the pharmaceutical field across the wide range of dosage forms, drug delivery systems (micro and nanoparticulate), at the regulatory front and on new types of therapies in the market. This volume additionally covers the challenges on drug delivery systems in terms of preclinical and current ways of determining quality and the options to solve the challenges associated with this. Most small-medium scale industries and academics struggle with initial regulatory challenges so a detailed discussion on regulatory trend covers the necessary basic understanding of regulatory procedures and provides the required guidance. The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers. Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems. Encompasses trends in drug delivery systems and selected dosage forms Illustrates regulatory, preclinical and quality principles Contains in-depth investigation of upcoming types of drug delivery systems

This book offers an authoritative review of biopharmaceuticals and their clinical relevance. Biopharmaceuticals have been showing high therapeutic potential by means of biological and biosimilar medicines, particularly for the treatment of cancer, chronic diseases (e.g. diabetes, Crohn's disease, psoriasis and rheumatoid arthritis), neurodegenerative disorders (e.g. multiple sclerosis), and they have also been contributing to the progress of innovative therapies such as assisted reproductive medicine. Since the eighties, several biopharmaceuticals have been approved and, due to patents expiration, many biosimilars are also marketed. In this book, readers will find the most relevant updated information about the main clinical applications of pharmaceutical biotechnology. The authors provide expert analysis about the industrial challenges of recombinant proteins and the different classes of biopharmaceuticals, including monoclonal antibodies, vaccines, growth factors and stem cells. Topics such as bioprinting technologies in tissue engineering, gene therapy and personalized medicine are also covered in this book. Professionals, students and researchers interested in this field will find this work an important account.

ADVANCES in NOVEL FORMULATIONS for DRUG DELIVERY The 27 chapters describe novel strategies for drug/nutraceutical delivery and embrace the development of formulations with herbal ingredients, while also highlighting disease therapeutics. Drug delivery technology has witnessed many advancements purported to cater to the customized needs of its ultimate beneficiaries—the patients. Today, dosage forms are not confined to conventional tablets, capsules, or injectables, but have evolved to cover novel drug carriers such as particulates, vesicles, and many others. Nanotechnological advancements have played a major role in this paradigm shift in ways of delivering active pharmaceutical ingredients. A new dimension in the use of food as medicine has also gained prominence in recent years. A portmanteau of nutrition and pharmaceuticals is “nutraceuticals,” also known as functional foods and dietary supplements. The technologies which were earlier included in drug delivery have been attempted for the delivery of nutraceuticals as well. Herbal actives have received increased attention due to their low risk-to-benefit ratio. The field of drug delivery is quite dynamic in nature, as witnessed by its evolution from conventional dosage forms to nanotechnology-assisted drug products. A variety of formulations via different drug delivery routes have been developed to treat/cure/mitigate diseases or disorders. This book, comprising of 27 chapters, is a thorough compilation of information relevant to drug delivery systems with an emphasis on products based on nanotechnology. Audience Researchers, scientists, industry professionals, formulators and product developers, regulatory agencies in a variety of settings including novel drug delivery research laboratories, pharmaceutical, and pharmacy industries, biomedical sciences, food and nutraceuticals manufacturers, and nanotechnology.